Share
translational vascular medicine: pathogenesis, diagnosis, and treatment (in English)
David Abraham
(Illustrated by)
·
Clive Handler
(Illustrated by)
·
Michael Dashwood
(Illustrated by)
·
Springer
· Hardcover
translational vascular medicine: pathogenesis, diagnosis, and treatment (in English) - Abraham, David ; Handler, Clive ; Dashwood, Michael
$ 173.05
$ 288.42
You save: $ 115.37
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: United Kingdom
(Import costs included in the price)
It will be shipped from our warehouse between
Thursday, May 30 and
Tuesday, June 11.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "translational vascular medicine: pathogenesis, diagnosis, and treatment (in English)"
Translational medicine underpins vascular medicine. It is fundamental to understanding how we treat patients with vascular disease and more importantly, how to prevent it. It is the rationale for drug design and production. Vascular medicine and translational medicine will take over and become the main reason for referring patients to hospital. Therefore, hospital-based clinicians working with basic scientists need to know about translational medicine, which educates and informs them about vascular medicine and how management should be based. Newly qualified and trained physicians are working in multidisciplinary groups of cardiologists, vascular surgeons, cardiac surgeons, lipidologists, diabetologists. Clinicians in the US, Australasia, the Far East and western Europe are interested in the molecular basis and treatments of vascular medicine and this encompasses translational medicine. This book is a primer for translational vascular medicine and discusses the evolving and exciting areas of basic science applied to vascular medicine. The book is based on the third vascular biology conference held at The Royal College of Physicians in 2008. It provides a large amount of new basic and clinical information and the contributors are world leaders.
